Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the US Ending the HIV Epidemic jurisdictions

被引:29
|
作者
Sullivan, Patrick S. [1 ]
Mouhanna, Farah [2 ,4 ]
Mera, Robertino [3 ]
Pembleton, Elizabeth [1 ]
Castel, Amanda D. [2 ]
Jaggi, Chandni [1 ]
Jones, Jeb [1 ]
Kramer, Michael R. [1 ]
McGuinness, Pema [1 ]
McCallister, Scott [3 ]
Siegler, Aaron J. [4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[2] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol, Washington, DC USA
[3] Gilead Sci, Foster City, CA USA
[4] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA
关键词
HIV prevention; HIV pre-exposure prophylaxis; Pharmacy data; UNITED-STATES; ANTIRETROVIRAL PROPHYLAXIS; MEN; SEX; SURVEILLANCE; PREVENTION; INFECTION; RISK;
D O I
10.1016/j.annepidem.2020.01.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Pre-exposure prophylaxis (PrEP) is a pillar of the US Department of Health and Human Services "Ending the HIV Epidemic" (EHE) initiative in 50 EHE jurisdictions (48 U.S. counties and two U.S. cities) and seven U.S. states with high numbers of HIV diagnoses rates in rural areas. Current data systems do not provide data on PrEP uptake in counties or cities. Methods: We report on PrEP users at the county level. Data from a large, commercial pharmacy database were used; we applied the U.S. Census Bureau's method to allocate PrEP users within a ZIP3 into counties and validated the results. We report counts and rates of PrEP users in 2018 for all EHE jurisdictions. We used joinpoint regression to model the estimated annual percent change in PrEP use for each jurisdiction and state. Results: 93,156 people in the 50 EHE jurisdictions used PrEP in 2018; 94% were men and 39% were aged 25-34 years. There was more than an 80-fold difference in the range of rates of PrEP use per 100,000 population among the EHE jurisdictions (range: 8-644 per 100,000 population; median 93 per 100,000 population). PrEP use increased from 2012 to 2018 in all EHE counties and states. At current rates of growth of PrEP use, 94% of EHE counties and jurisdictions will reach their National HIV/AIDS Strategy goals of a 500% increase in PrEP use in 2020. EHE states had less variation in rates of PrEP use (range: 29 -51/100,000 population; median 32/100,000 population). Conclusions: At the outset of a major U.S. government program to reduce HIV infections, rates of PrEP use are highly variable among the 50 EHE jurisdictions. Data from commercial prescription databases will be a useful public resource to understand progress in promoting use of PrEP as part of the EHE initiative and evaluating progress in PrEP use across health jurisdictions. (C) 2020 The Authors. Published by Elsevier Inc.
引用
收藏
页码:16 / 30
页数:15
相关论文
共 50 条
  • [21] Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany
    Valbert, Frederik
    Schmidt, Daniel
    Kollan, Christian
    Droege, Patrik
    Klein, Melanie
    Schneider, Udo
    Friebe, Martin
    Wasem, Juergen
    Neumann, Anja
    ARCHIVES OF SEXUAL BEHAVIOR, 2024, 53 (09) : 3663 - 3672
  • [22] ASSOCIATION OF SOCIAL DETERMINANTS OF HEALTH AND HIV PRE-EXPOSURE PROPHYLAXIS (PREP) TO NEED RATIO ON THE COUNTY LEVEL IN THE UNITED STATES
    Zaki, S.
    Goswami, S.
    Vivek, V.
    Aparasu, R.
    VALUE IN HEALTH, 2023, 26 (06) : S280 - S280
  • [23] Readiness of US Federally Qualified Health Centers to Provide HIV Pre-exposure Prophylaxis
    Ard, Kevin L.
    Uzoeghelu, Ugochukwu
    Bruno, Jack
    Lambert, Cei
    Mayer, Kenneth H.
    Davis, John A.
    Keuroghlian, Alex S.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (10):
  • [24] County-Level Spatiotemporal Patterns of New HIV Diagnoses and Pre-exposure Prophylaxis (PrEP) Use in Mississippi, 2014-2018: A Bayesian Analysis of Publicly Accessible Censored Data
    Luan, Hui
    Ransome, Yusuf
    ANNALS OF THE AMERICAN ASSOCIATION OF GEOGRAPHERS, 2023, 113 (01) : 129 - 148
  • [25] An Emerging Substance Use Epidemic: Recreational Use of HIV Pre-Exposure Prophylaxis and Treatment in South Africa
    Kuo, Caroline
    Dietrich, Janan
    Slingers, Nevilene
    Beauclair, Roxanne
    Lombard, Carl
    Mathews, Catherine
    AIDS PATIENT CARE AND STDS, 2021, 35 (03) : 92 - 101
  • [26] HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges
    Assoumou, Sabrina A.
    Paniagua, Samantha M.
    Gonzalez, Priscilla
    Wang, Jianing
    Beckwith, Curt G.
    White, Laura F.
    Taylor, Jessica L.
    Coogan, Kristen
    Samet, Jeffrey H.
    Linas, Benjamin P.
    AIDS AND BEHAVIOR, 2021, 25 (08) : 2591 - 2598
  • [27] HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges
    Sabrina A. Assoumou
    Samantha M. Paniagua
    Priscilla Gonzalez
    Jianing Wang
    Curt G. Beckwith
    Laura F. White
    Jessica L. Taylor
    Kristen Coogan
    Jeffrey H. Samet
    Benjamin P. Linas
    AIDS and Behavior, 2021, 25 : 2591 - 2598
  • [28] A COST-EFFECTIVENESS ANA LYSIS OF PRE-EXPOSURE PROPHYLAXIS FOR HIV: A US PAYER PERSPECTIVE
    Vaidya, N.
    Campbell, J. D.
    VALUE IN HEALTH, 2015, 18 (03) : A236 - A237
  • [29] Barriers to accessing HIV pre-exposure prophylaxis (PrEP) in Germany during health insurance coverage of PrEP
    Koppe, U.
    Marcus, U.
    Albrecht, S.
    Jansen, K.
    Gunsenheimer-Bartmeyer, B.
    Bremer, V.
    HIV MEDICINE, 2021, 22 : 278 - 278
  • [30] HIV Pre-exposure Prophylaxis (PrEP) - between Approval and Cost Coverage by the statutory Health Insurance Company
    Ahaus, P.
    Potthoff, A.
    Kayser, A.
    Wach, J.
    Brockmeyer, N. H.
    Skaletz-Rorowski, A.
    HAUTARZT, 2021, 72 (SUPPL 1): : S8 - S8